2602 Pazopanib (Pz) as first line for metastatic renal carcinoma (mRC): Updated validation of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model (IMRCC). The SPAZO study (SOGUG)
Perez-Valderrama, B, Arija, J.A. Arranz, Vidal, M.J. Méndez, Carbonero, I. García, Rodríguez, C. Suárez, Gallego, P. Jiménez, López-Brea, M, Marrero, R.D. García, García, J.A. Meana, Gajate, P, Santander, C, Palau, C. Molins, Parra, E.M. Fernández, Torras, O. Reig, Basterrechea, L, Estévez, S. Vázquez, Borrega, P, Sánchez, A. Rodríguez, Pinto, A, Castellano, D.E
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
2638 Effectiveness of 2nd-line and subsequent therapies after pazopanib (Paz) in patients (pt) with metastatic renal cell carcinoma (mRCC): Final results of the SPAZO study (SOGUG)
Arija, J.A. Arranz, Pérez-Valderrama, B, González-Larriba, J.L, Rodríguez Sánchez, A, Chirivella, I, Pinto, A, Marrero, R.D. García, Rubio, G, García, J.M. Jurado, Borrega, P, Quintela, M. Lázaro, Castellano, D.E, Rodríguez, C. Suárez, García, J.A. Meana, Lambea-Sorrosal, J.J, Gajate, P, Fita, M.J. Juan, Puertas, J.L, Domínguez, R. García, Guzmán, J.C. Villa
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
165 (PB153): NEXUS-01, a phase 1 study of LY4052031, an antibody-drug conjugate targeting Nectin-4 in participants with advanced or metastatic urothelial carcinoma or other solid tumors (Trial in Progress)
Baldini, C., Patnaik, A., Lakhani, N., Call, J., Galsky, M., Garmezy, B., Wei, A., Carter, L., Powles, T., Siefker-Radtke, A., O’Donnell, P.H., Kitano, S., Castellano, D.E., Shinde, R., Joshua, A.M., Balbas, M., Han, H., Chang, A.E., Gao, X., Iyer, G.
Published in European journal of cancer (1990) (01.10.2024)
Published in European journal of cancer (1990) (01.10.2024)
Get full text
Journal Article
Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up
Balar, A.V., Castellano, D.E., Grivas, P., Vaughn, D.J., Powles, T., Vuky, J., Fradet, Y., Lee, J.-L., Fong, L., Vogelzang, N.J., Climent, M.A., Necchi, A., Petrylak, D.P., Plimack, E.R., Xu, J.Z., Imai, K., Moreno, B.H., Bellmunt, J., de Wit, R., O’Donnell, P.H.
Published in Annals of oncology (01.03.2023)
Published in Annals of oncology (01.03.2023)
Get full text
Journal Article
1601P First results from ZZFIRST: A randomized phase II trial of enzalutamide (EZ) with or without talazoparib (TALA) in metastatic hormone-naïve prostate cancer (mHNPC)
Mateo, J., Castro, E., Rodriguez-Vida, A., Gonzalez, B. Mellado, Gauna, D.E. Castellano, Climent Duran, M.A., Fernando, A. Borque, Sáez, M.I., Imbroda, B. Herrera, Pous, A. Font, Lorente, D., Morin, J. Planas, Vivancos, A., Cardona, J., Guerrero, J.A., Perez-Escuredo, J., Saavedra, A.J. Zurita, Galceran, J.C.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma
Garcia-Donas, J., Leandro-García, L.J., González del Alba, A., Morente, M., Alemany, I., Esteban, E., Arranz, J.A., Climent, M.A., Gallardo, E., Castellano, D.E., Bellmunt, J., Mellado, B., Puente, J., Moreno, F., Font, A., Hernando, S., Robledo, M., Rodríguez-Antona, C.
Published in Annals of oncology (01.09.2013)
Published in Annals of oncology (01.09.2013)
Get full text
Journal Article
Prognostic Factors for Survival and Sequencing of Life-Extending Therapies in Metastatic Castration Resistant Prostate Cancer (Mcrpc) Patients (Pts) in Post-Docetaxel (D) Setting
Oudard, S., Angelergues, A., Maeso, I. Gonzalez, Delanoy, N., Flechon, A., Özgüroğlu, M., Castellano, D.E., Guillot, A., Le Moulec, S., Esteban, E., Munarriz, J., Campos, B., Bellmunt, J.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
789PPROGNOSTIC FACTORS FOR SURVIVAL AND SEQUENCING OF LIFE-EXTENDING THERAPIES IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) PATIENTS (PTS) IN POST-DOCETAXEL (D) SETTING
Oudard, S., Angelergues, A., Maeso, I. Gonzalez, Delanoy, N., Flechon, A., Özgüroğlu, M., Castellano, D.E., Guillot, A., Le Moulec, S., Esteban, E., Munarriz, J., Campos, B., Bellmunt, J.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Cabazitaxel in Patients with Advanced CRPC after Docetaxel-Failure. Results of Expanded Program Access (EAP) in Spain: Safety and Efficacy
Castellano, D.E., Aparicio, L.M. Anton, Esteban, E., Velasco, G., Perez, Q., Sanchez, A., Pérez-Valderrama, B., Batista, N.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
783PPRELIMINARY RESULTS OF A PHASE II STUDY OF WEEKLY CABAZITAXEL IN "UNFIT" METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PATIENTS PROGRESSING AFTER DOCETAXEL TREATMENT (SOGUG-CABASEM TRIAL)
Pérez-Valderrama, B., Mellado, B., Juan, M.J., Fernandez, O., Fernández-Parra, E., de Olza, M. Ochoa, Castellano, D.E., Anido, U., Domenech, M., Hernando, S., Arija, J. Arranz, Caballero, C., Duran, I., Campayo, M., Chilet, M., Climent, M.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Preliminary Results of a Phase Ii Study of Weekly Cabazitaxel in "Unfit" Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Patients Progressing After Docetaxel Treatment (Sogug-Cabasem Trial)
Pérez-Valderrama, B., Mellado, B., Juan, M.J., Fernandez, O., Fernández-Parra, E., de Olza, M. Ochoa, Castellano, D.E., Anido, U., Domenech, M., Hernando, S., Arija, J. Arranz, Caballero, C., Duran, I., Campayo, M., Chilet, M., Climent, M.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Tissue Microarray (TMA) and VHL Mutations as Predictors of Outcome in Advanced Clear Cell Renal Cell Carcinoma (CCRCC) Treated with Firs Line Sunitinib
Rodríguez-Moreno, J.F., Esteban, E., Morente, M., Alemany, I., Castellano, D.E., Del Alba, A. Gonzalez, Climent, M., Rodriguez-Antona, C., Garcia-Donas, J.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Genetic Polymorphisms and Sunitinib Toxicity in Metastatic Renal-Cell Carcinoma
Sanchez, J. Sepulveda, Farfan, C., Villacampa, F., Velasco, G., Benitez, J., Rodriguez, C., Calderon, M., Cañamares, I., Cortes-Funes, H., Castellano, D.E.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Phase II Clinical and Pharmacokinetic (PK) Trial of Zalypsis (Z) in Patients with Urothelial Carcinoma (UC) Progressing after a First-Line Platinum-Based Regimen
Carles, J., Bellmunt, J., Maroto, P., Font, A., Morales-Barrera, R., Suarez, C., Lorente, C. Martin, Etxaniz, O., Capdevila, L., Castellano, D.E.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
1611P Haematologic impact of [177Lu]Lu-PSMA-617 versus ARPI change in patients with metastatic castration-resistant prostate cancer in PSMAfore
Chi, K.N., Sartor, O., Fizazi, K., de Bono, J.S., Shore, N.D., Herrmann, K., Castellano Gauna, D.E., Piulats Rodriguez, J.M., Flechon, A., Wei, X.X., Kim, H., Schweizer, M., Alanee, S., Ghebremariam, S., Hertelendi, M., Morris, M.J.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1982P Post hoc analysis of outcomes according to prior chemotherapy (CT) response and platinum agent in the international SAUL study of atezolizumab (atezo) for urinary tract carcinoma (UTC)
Perez Valderrama, B., Garcia Del Muro, X., Merseburger, A.S., Loriot, Y., Choy, E., Castellano Gauna, D.E., Lopez-Rios, F., Bonfill Abella, T., Montesa Pino, A., Yu, P., Skamnioti, P., Sternberg, C.N.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1599P Symptomatic skeletal events, health-related quality of life and pain in a phase III study of [177Lu]Lu-PSMA-617 in taxane-naive patients with PSMA-positive metastatic castration-resistant prostate cancer: Third interim analysis of PSMAfore
Fizazi, K., Morris, M.J., Shore, N.D., Chi, K.N., Crosby, M., de Bono, J.S., Herrmann, K., Roubaud, G., Nagarajah, J., Fleming, M.T., Lewis, B., Nordquist, L.T., Castellano Gauna, D.E., Carnahan, N., Ghebremariam, S., Hertelendi, M., Sartor, O.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1768P Clinical outcomes with platinum-based chemotherapy after progression on frontline immunotherapy in metastatic urothelial cancer (mUC)
Szabados, B.E., Stockem, C.F., Castellano Gauna, D.E., Gomez de Liano Lista, A., Rey Cardenas, M., Perez Valderrama, B., Powles, T.B., van der Heijden, M.S.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
2409TiP A global, multicentre, open-label, randomised phase II trial of tobemstomig (tobe) with or without tiragolumab (tira) vs atezolizumab (atezo) in patients (pts) with untreated metastatic urothelial cancer (mUC) ineligible for platinum-based chemotherapy (chemo)
Gupta, S., Alhalabi, O., Bamias, A., Bellmunt, J., Castellano Gauna, D.E., Bedke, J., Friedlander, T., Garmezy, B., Grivas, P., Huddart, R.A., Necchi, A., Powles, T.B., Puente, J., Da Rosa, D.A.R., Wang, F., Lambertini, C., Andreev-Drakhlin, A., Fasso, M., Loriot, Y.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
2366P Phase I-II study of niraparib plus cabozantinib in patients with advanced urothelial/kidney cancer (NICARAGUA trial)
Castellano Gauna, D.E., Duran Martinez, I., Mellado Gonzalez, B., Climent Duran, M.A., Garcia Del Muro, X., Sala González, N., Alonso Gordoa, T., Sevillano Fernandez, E., Domenech Santasusana, M., Paramio, J., Real, F.X., Malats, N., Font Pous, A.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article